Role of staphylococcal enterotoxin A in a fatal case of endocarditis

Journal of Medical Microbiology

Volumn 52, Issue 2, 2003, Pages 109-112

  Ellis, M ^a   Serreli, A ^b   Colque Navarro, P ^b   Hedstrom, U ^c   Chacko, A ^d   Siemkowicz, E ^d   Mollby R ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; AZITHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; STAPHYLOCOCCUS ENTEROTOXIN A;

ADULT; ANTIBODY PRODUCTION; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; CASE REPORT; FEMALE; HUMAN; IMMUNOMODULATION; MITRAL VALVE REPLACEMENT; OTITIS MEDIA; PRIORITY JOURNAL; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME;

EID: 0037320381     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05003-0     Document Type: Article

References (15)

1. Cassada, D. C., Moniz, M., Stevens, S. L., Freeman, M. B., Goldman, M. H. & Schuchmann, G. S. (1999). Factors affecting the surgical management of infective endocarditis. Am Surg 65, 307-310.
2. Colque-Navarro, P., Söderquist, B., Holmberg, H., Blomqvist, L., Olcen, P. & Möllby, R. (1998). Antibody response in Staphylococcus aureus septicaemia -a prospective study. J Med Microbiol 47, 217-225.
3. Colque-Navarro, P., Palma, M., Söderquist, B., Flock, J.-I. & Möllby, R. (2000). Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol 7, 14-20.
4. Dinges, M. M., Orwin, P. M. & Schlievert, P. M. (2000). Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13, 16-34.
5. Fowler, V. G., Jr, ki, J., Corey, G. R. & 8 other authors (1997). Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30, 1072-1078.
6. Gentry, C. A., Rodvold, K. A., Novak, R. M., Hershow, R. C. & Naderer, O. J. (1997). Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Pharmacotherapy 17, 990-997.
7. Kanclerski, K., Söderquist, B., Kjellgren, M., Holmberg, H. & Möllby, R. (1996). Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia. J Med Microbiol 44, 171-177.
8. Kaul, R., McGreer, A., Norrby-Teglund, A., Kotb, M., Schwartz, B., O'Rourke, K., Talbot, J. & Low, D. E. (1999). Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome -a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 28, 800-807.
9. LeClaire, R. D. & Bavari, S. (2001). Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob Agents Chemother 45, 460-463.
10. Möllby, R. (1983). Isolation and properties of membrane damaging toxins. In Staphylococci and Staphylococcal Infections, vol. 2, pp. 628-630. Edited by C. S. F. Easmon & C. Adams. London: Academic Press.
11. Monday, S. R. & Bohach, G. A. (1999). Properties of Staphylococcus aureus enterotoxins and toxic shock syndrome toxin-1. In The Comprehensive Sourcebook of Bacterial Toxins, 2nd edn, pp. 589-609. Edited by J. E. Alouf & J. H. Freer. London: Academic Press.
12. Norrby-Teglund, A., Basma, H., Andersson, J., McGreer, A., Low, D. E. & Kotb, M. (1998). Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal poly-specific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis 26, 631-638.
13. Roder, B. L., Wandall, D. A., Frimodt-Moller, N., Espersen, F., Skinhoj, P. & Rosdahl, V. T. (1999). Clinical features of Staphylococcus aureus endocarditis, a 10-year experience in Denmark. Arch Intern Med 159, 462-469.
14. Watanakunakorn, C. (1994). Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases. Arch Intern Med 154, 2330-2335.
15. Working Party of the British Society for Antimicrobial Chemotherapy (1998). Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 79, 207-210.